Viewing Study NCT01780051


Ignite Creation Date: 2025-12-24 @ 11:38 PM
Ignite Modification Date: 2026-02-25 @ 7:22 PM
Study NCT ID: NCT01780051
Status: COMPLETED
Last Update Posted: 2013-05-15
First Post: 2013-01-29
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Pharmacokinetic Study to Compare Co-administration of Repaglinide and Metformin HCl to Administration of Combination Preparation of Those Two Components
Sponsor: Dalim BioTech Co., Ltd.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Diabetes Mellitus, Type 2 View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Diabetes Mellitus, Type 2 View
None Pharmacokinetics View